Octreotide needle-free injectable

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOctreotide needle-free injectable
Drug Alias NameGlide octreotideoctreotide SDIGP-02
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor agonists
TargetsGrowth hormone releasing factor
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlide Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAcromegaly

Other Information

ATC CodeH01CB02
Related LinksN/A